anti-idiotype GAD65 antibody (North Coast Biologics)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-idiotype GAD65 antibody (North Coast Biologics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionGlutamate decarboxylase 2 inhibitors
TargetsGlutamate decarboxylase 2
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorth Coast Biologics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorth Coast Biologics LLC
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A